Release Date: 08/05/23 08:15 Summary: Change of substantial holding from RMS Price Sensitive: No Download Document 96.96KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%